New York, NY - Growing Stock Report initiates a Drug Stock Watch List adding Merck & Co. Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE) and Abbott Laboratories (NYSE:ABT).
Merck & Co. Inc. (NYSE:MRK) a company that provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide closed up (+3.16%) in it's previous trading session after the Data Safety Monitoring Board concluded that it should continue with its study of cholesterol-lowering drug Vytorin. Merck & Co. Inc. (NYSE:MRK) is currently up (+21.66%) from it's 52 week low of $37.02 which has prompted Growing Stock Report to add the Company to their Drug Stock Watch List and Investor Poll.
To find out what other Investors are saying about Merck & Co. Inc. (NYSE:MRK)
Click Here: http://www.growingstockreport.com/Survey.aspx?stock=MRK&SubId=AW
Pfizer Inc. (NYSE:PFE) a biopharmaceutical compay that discovers, develops, manufactures, and sells medicines for people and animals worldwide closed down (-1.06%) in it's previous trading session after a Heart Warning was Added to Pfizer’s ‘Z-Pak’ Antibiotic by the FDA. The medicine generated about $435 million for New York-based Pfizer in 2012. Pfizer Inc. (NYSE:PFE) is currently up (+32.62%) from it's 52 weel low of $21.40 which has prompted Growing Stock Report to add the stock to their Drug Stock Watch List and Investor Poll.
To find out what other Investors are saying about Pfizer Inc. (NYSE:PFE)
Click Here: http://www.growingstockreport.com/Survey.aspx?stock=PFE&SubId=AW
Abbott Laboratories (NYSE:ABT) a company that engages in the discovery, development, manufacture, and sale of health care products worldwide closed up (+0.14%) in it's previous trading session after recently reporting positive long-term results for its innovative Absorb Bioresorbable Vascular Scaffold. Absorb is commercially available in Europe and other international markets, but is an investigational device in the United States. Abbott Laboratories (NYSE:ABT) is currently up (+24.57%) from it's 52 week low of $28.08 which has prompted Growing Stock Report to add the stock to their Drug Stock Watch List and Investor Poll.
To find out what other Investors are saying about Abbott Laboratories (NYSE:ABT)
Click Here: http://www.growingstockreport.com/Survey.aspx?stock=ABT&SubId=AW
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Contact Info:
Growing Stock Report
editor@GrowingStockReport.com